The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA

Research output: Contribution to journalArticlepeer-review

Standard

The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer : a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA. / Pritchard-Jones, Kathy; de C. V. Abib, Aimone; Esiashvili, Natia; Kaspers, Gertjan J. L.; Rosser, Jon; Van Doorninck, John A.; Braganca, Joao M. L.; Hoffman, Ruth I.; Rodriguez-Galindo, Carlos; Adams, Cary; Connor, Stephen R.; Abdelhafeez, Abdelhafeez H.; Bouffet, Eric; Howard, Scott C.; Challinor, Julia M.; Hessissen, Laila; Dalvi, Rashmi B.; Kearns, Pamela; Chantada, Guillermo L.; Frazier, Lindsay A.; Sullivan, Michael J.; Schulte, Fiona S. M.; Morrissey, Lisa K.; Kozhaeva, Olga; Luna-Fineman, Sandra ; Khan, Muhammad S.

In: Ecancermedicalscience, Vol. 15, 1187, 15.02.2021.

Research output: Contribution to journalArticlepeer-review

Harvard

Pritchard-Jones, K, de C. V. Abib, A, Esiashvili, N, Kaspers, GJL, Rosser, J, Van Doorninck, JA, Braganca, JML, Hoffman, RI, Rodriguez-Galindo, C, Adams, C, Connor, SR, Abdelhafeez, AH, Bouffet, E, Howard, SC, Challinor, JM, Hessissen, L, Dalvi, RB, Kearns, P, Chantada, GL, Frazier, LA, Sullivan, MJ, Schulte, FSM, Morrissey, LK, Kozhaeva, O, Luna-Fineman, S & Khan, MS 2021, 'The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA', Ecancermedicalscience, vol. 15, 1187. https://doi.org/10.3332/ecancer.2021.1187

APA

Pritchard-Jones, K., de C. V. Abib, A., Esiashvili, N., Kaspers, G. J. L., Rosser, J., Van Doorninck, J. A., Braganca, J. M. L., Hoffman, R. I., Rodriguez-Galindo, C., Adams, C., Connor, S. R., Abdelhafeez, A. H., Bouffet, E., Howard, S. C., Challinor, J. M., Hessissen, L., Dalvi, R. B., Kearns, P., Chantada, G. L., ... Khan, M. S. (2021). The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA. Ecancermedicalscience, 15, [1187]. https://doi.org/10.3332/ecancer.2021.1187

Vancouver

Author

Pritchard-Jones, Kathy ; de C. V. Abib, Aimone ; Esiashvili, Natia ; Kaspers, Gertjan J. L. ; Rosser, Jon ; Van Doorninck, John A. ; Braganca, Joao M. L. ; Hoffman, Ruth I. ; Rodriguez-Galindo, Carlos ; Adams, Cary ; Connor, Stephen R. ; Abdelhafeez, Abdelhafeez H. ; Bouffet, Eric ; Howard, Scott C. ; Challinor, Julia M. ; Hessissen, Laila ; Dalvi, Rashmi B. ; Kearns, Pamela ; Chantada, Guillermo L. ; Frazier, Lindsay A. ; Sullivan, Michael J. ; Schulte, Fiona S. M. ; Morrissey, Lisa K. ; Kozhaeva, Olga ; Luna-Fineman, Sandra ; Khan, Muhammad S. / The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer : a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA. In: Ecancermedicalscience. 2021 ; Vol. 15.

Bibtex

@article{14a00f331650457381e4537441bf766f,
title = "The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA",
abstract = "The COVID-19 pandemic poses an unprecedented health crisis in all socio-economic regions across the globe. While the pandemic has had a profound impact on access to and delivery of health care by all services, it has been particularly disruptive for the care of patients with life-threatening noncommunicable diseases (NCDs) such as the treatment of children and young people with cancer.The reduction in child mortality from preventable causes over the last 50 years has seen childhood cancer emerge as a major unmet health care need. Whilst survival rates of 85% have been achieved in high income countries, this has not yet been translated into similar outcomes for children with cancer in resource-limited settings where survival averages 30%. Launched in 2018, by the World Health Organization (WHO), the Global Initiative for Childhood Cancer (GICC) is a pivotal effort by the international community to achieve at least 60% survival for children with cancer by 2030.The WHO GICC is already making an impact in many countries but the disruption of cancer care during the COVID-19 pandemic threatens to set back this global effort to improve the outcome for children with cancer, wherever they may live.As representatives of the global community committed to fostering the goals of the GICC, we applaud the WHO response to the COVID-19 pandemic, in particular we support the WHO{\textquoteright}s call to ensure the needs of patients with life threatening NCDs including cancer are not compromised during the pandemic. Here, as collaborative partners in the GICC, we highlight specific areas of focus that need to be addressed to ensure the immediate care of children and adolescents with cancer is not disrupted during the pandemic; and measures to sustain the development of cancer care so the long-term goals of the GICC are not lost during this global health crisis.",
keywords = "COVID-19, neoplasms, children, paediatric, policy, global",
author = "Kathy Pritchard-Jones and {de C. V. Abib}, Aimone and Natia Esiashvili and Kaspers, {Gertjan J. L.} and Jon Rosser and {Van Doorninck}, {John A.} and Braganca, {Joao M. L.} and Hoffman, {Ruth I.} and Carlos Rodriguez-Galindo and Cary Adams and Connor, {Stephen R.} and Abdelhafeez, {Abdelhafeez H.} and Eric Bouffet and Howard, {Scott C.} and Challinor, {Julia M.} and Laila Hessissen and Dalvi, {Rashmi B.} and Pamela Kearns and Chantada, {Guillermo L.} and Frazier, {Lindsay A.} and Sullivan, {Michael J.} and Schulte, {Fiona S. M.} and Morrissey, {Lisa K.} and Olga Kozhaeva and Sandra Luna-Fineman and Khan, {Muhammad S.}",
year = "2021",
month = feb,
day = "15",
doi = "10.3332/ecancer.2021.1187",
language = "English",
volume = "15",
journal = "Ecancermedicalscience",
issn = "1754-6605",
publisher = "Cancer Intelligence Ltd",

}

RIS

TY - JOUR

T1 - The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer

T2 - a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA

AU - Pritchard-Jones, Kathy

AU - de C. V. Abib, Aimone

AU - Esiashvili, Natia

AU - Kaspers, Gertjan J. L.

AU - Rosser, Jon

AU - Van Doorninck, John A.

AU - Braganca, Joao M. L.

AU - Hoffman, Ruth I.

AU - Rodriguez-Galindo, Carlos

AU - Adams, Cary

AU - Connor, Stephen R.

AU - Abdelhafeez, Abdelhafeez H.

AU - Bouffet, Eric

AU - Howard, Scott C.

AU - Challinor, Julia M.

AU - Hessissen, Laila

AU - Dalvi, Rashmi B.

AU - Kearns, Pamela

AU - Chantada, Guillermo L.

AU - Frazier, Lindsay A.

AU - Sullivan, Michael J.

AU - Schulte, Fiona S. M.

AU - Morrissey, Lisa K.

AU - Kozhaeva, Olga

AU - Luna-Fineman, Sandra

AU - Khan, Muhammad S.

PY - 2021/2/15

Y1 - 2021/2/15

N2 - The COVID-19 pandemic poses an unprecedented health crisis in all socio-economic regions across the globe. While the pandemic has had a profound impact on access to and delivery of health care by all services, it has been particularly disruptive for the care of patients with life-threatening noncommunicable diseases (NCDs) such as the treatment of children and young people with cancer.The reduction in child mortality from preventable causes over the last 50 years has seen childhood cancer emerge as a major unmet health care need. Whilst survival rates of 85% have been achieved in high income countries, this has not yet been translated into similar outcomes for children with cancer in resource-limited settings where survival averages 30%. Launched in 2018, by the World Health Organization (WHO), the Global Initiative for Childhood Cancer (GICC) is a pivotal effort by the international community to achieve at least 60% survival for children with cancer by 2030.The WHO GICC is already making an impact in many countries but the disruption of cancer care during the COVID-19 pandemic threatens to set back this global effort to improve the outcome for children with cancer, wherever they may live.As representatives of the global community committed to fostering the goals of the GICC, we applaud the WHO response to the COVID-19 pandemic, in particular we support the WHO’s call to ensure the needs of patients with life threatening NCDs including cancer are not compromised during the pandemic. Here, as collaborative partners in the GICC, we highlight specific areas of focus that need to be addressed to ensure the immediate care of children and adolescents with cancer is not disrupted during the pandemic; and measures to sustain the development of cancer care so the long-term goals of the GICC are not lost during this global health crisis.

AB - The COVID-19 pandemic poses an unprecedented health crisis in all socio-economic regions across the globe. While the pandemic has had a profound impact on access to and delivery of health care by all services, it has been particularly disruptive for the care of patients with life-threatening noncommunicable diseases (NCDs) such as the treatment of children and young people with cancer.The reduction in child mortality from preventable causes over the last 50 years has seen childhood cancer emerge as a major unmet health care need. Whilst survival rates of 85% have been achieved in high income countries, this has not yet been translated into similar outcomes for children with cancer in resource-limited settings where survival averages 30%. Launched in 2018, by the World Health Organization (WHO), the Global Initiative for Childhood Cancer (GICC) is a pivotal effort by the international community to achieve at least 60% survival for children with cancer by 2030.The WHO GICC is already making an impact in many countries but the disruption of cancer care during the COVID-19 pandemic threatens to set back this global effort to improve the outcome for children with cancer, wherever they may live.As representatives of the global community committed to fostering the goals of the GICC, we applaud the WHO response to the COVID-19 pandemic, in particular we support the WHO’s call to ensure the needs of patients with life threatening NCDs including cancer are not compromised during the pandemic. Here, as collaborative partners in the GICC, we highlight specific areas of focus that need to be addressed to ensure the immediate care of children and adolescents with cancer is not disrupted during the pandemic; and measures to sustain the development of cancer care so the long-term goals of the GICC are not lost during this global health crisis.

KW - COVID-19

KW - neoplasms

KW - children

KW - paediatric

KW - policy

KW - global

U2 - 10.3332/ecancer.2021.1187

DO - 10.3332/ecancer.2021.1187

M3 - Article

VL - 15

JO - Ecancermedicalscience

JF - Ecancermedicalscience

SN - 1754-6605

M1 - 1187

ER -